GLP-1 drugs linked to lower addiction risk, study finds [USA TODAY]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: USA TODAY
The protective effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, nicotine and cannabis, adding further evidence to a phenomenon previously flagged in smaller studies. “That breadth was quite a surprise,” said Dr. Ziyad Al-Aly of the VA Saint Louis Health Care System in Missouri, who led the study published in The BMJ. “In addiction medicine, there's not a single drug that works across all these substances.” His team used a U.S. Veterans Affairs database to identify patients with type 2 diabetes treated with drugs from two different classes of medicines: GLP-1s such as Eli Lilly's LLY.N Trulicity or Mounjaro, and Novo Nordisk's NOVOb.CO Victoza or Ozempic; and SGLT-2 inhibitors such as Jardiance from Boehringer Ingelheim and Farxiga from AstraZeneca AZN.L. They then compared them in simulated randomized trials. For the most part, study participants were not taking the higher-dose GLP-1 drugs used to treat obesit
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- GLP-1 Receptor Agonist (Trulicity, Wegovy, Ozempic, Mounjaro) Market Trends Analysis Report 2026 [Yahoo! Finance]Yahoo! Finance
- Lilly Stock Down 5% in a Month: Should You Buy Now or Steer Clear? [Yahoo! Finance]Yahoo! Finance
- Third Annual Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston May 19 [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (LLY) had its "overweight" rating reaffirmed by Morgan Stanley.MarketBeat
- Eli Lilly Expands Obesity Access As Oral GLP-1 Data Shape Growth Story [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 2/19/26 - Form 4
- 2/18/26 - Form 4
- 2/18/26 - Form 4
- LLY's page on the SEC website